CUE vs IT · rev $9.3M vs P/E 16, rev $6.27B
Cue Biopharma (CUE) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
CUE currently screens at market cap $59.5M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the CUE and IT stock pages for the full models.
Not investment advice.